These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22829222)
1. Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells. Pommey S; Lu B; McRae J; Stagg J; Hill P; Salvaris E; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM Hepatology; 2013 Apr; 57(4):1597-606. PubMed ID: 22829222 [TBL] [Abstract][Full Text] [Related]
2. CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection. Yoshida O; Dou L; Kimura S; Yokota S; Isse K; Robson SC; Geller DA; Thomson AW Transpl Immunol; 2015 Mar; 32(2):76-83. PubMed ID: 25661084 [TBL] [Abstract][Full Text] [Related]
3. Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation. Ueki S; Castellaneta A; Yoshida O; Ozaki K; Zhang M; Kimura S; Isse K; Ross M; Shao L; Stolz DB; Thomson AW; Demetris AJ; Geller DA; Murase N Hepatology; 2011 Jul; 54(1):216-28. PubMed ID: 21503939 [TBL] [Abstract][Full Text] [Related]
4. Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury. Rajakumar SV; Lu B; Crikis S; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM Transplantation; 2010 Dec; 90(12):1260-4. PubMed ID: 21063242 [TBL] [Abstract][Full Text] [Related]
5. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. Day YJ; Huang L; Ye H; Li L; Linden J; Okusa MD J Immunol; 2006 Mar; 176(5):3108-14. PubMed ID: 16493070 [TBL] [Abstract][Full Text] [Related]
6. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Shen X; Wang Y; Gao F; Ren F; Busuttil RW; Kupiec-Weglinski JW; Zhai Y Hepatology; 2009 Nov; 50(5):1537-46. PubMed ID: 19670423 [TBL] [Abstract][Full Text] [Related]
8. CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice. Yoshida O; Kimura S; Jackson EK; Robson SC; Geller DA; Murase N; Thomson AW Hepatology; 2013 Dec; 58(6):2163-75. PubMed ID: 23813862 [TBL] [Abstract][Full Text] [Related]
9. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice. Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261 [TBL] [Abstract][Full Text] [Related]
10. Ischemia-reperfusion Injury in Allogeneic Liver Transplantation: A Role of CD4 T Cells in Early Allograft Injury. Kageyama S; Kadono K; Hirao H; Nakamura K; Ito T; Gjertson DW; Sosa RA; Reed EF; Kaldas FM; Busuttil RW; Kupiec-Weglinski JW; Zhai Y Transplantation; 2021 Sep; 105(9):1989-1997. PubMed ID: 33065722 [TBL] [Abstract][Full Text] [Related]
11. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury. Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716 [TBL] [Abstract][Full Text] [Related]
12. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Crikis S; Lu B; Murray-Segal LM; Selan C; Robson SC; D'Apice AJ; Nandurkar HH; Cowan PJ; Dwyer KM Am J Transplant; 2010 Dec; 10(12):2586-95. PubMed ID: 20840479 [TBL] [Abstract][Full Text] [Related]
13. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury. Roberts V; Campbell DJ; Lu B; Chia J; Cowan PJ; Dwyer KM Transplantation; 2017 Jul; 101(7):e194-e204. PubMed ID: 28198766 [TBL] [Abstract][Full Text] [Related]
14. Roles of dendritic cells in murine hepatic warm and liver transplantation-induced cold ischemia/reperfusion injury. Zhang M; Ueki S; Kimura S; Yoshida O; Castellaneta A; Ozaki KS; Demetris AJ; Ross M; Vodovotz Y; Thomson AW; B Stolz D; Geller DA; Murase N Hepatology; 2013 Apr; 57(4):1585-96. PubMed ID: 23184590 [TBL] [Abstract][Full Text] [Related]
15. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325 [TBL] [Abstract][Full Text] [Related]
16. Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation. Zhang Y; Ji H; Shen X; Cai J; Gao F; Koenig KM; Batikian CM; Busuttil RW; Kupiec-Weglinski JW Am J Transplant; 2013 Jan; 13(1):56-66. PubMed ID: 23137033 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury. Nowak-Machen M; Schmelzle M; Hanidziar D; Junger W; Exley M; Otterbein L; Wu Y; Csizmadia E; Doherty G; Sitkovsky M; Robson SC Am J Respir Cell Mol Biol; 2013 May; 48(5):601-9. PubMed ID: 23349052 [TBL] [Abstract][Full Text] [Related]